报价延迟最少15分钟:2026/04/26 11:08 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
18.7 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.41/1.54
|
|
企业价值
181.41M
|
| 资产负债 |
|
每股账面净值
0.19
|
| 现金流量 |
|
现金流量率
0.02
|
| 损益表 |
|
收益
44.05M
|
|
每股收益
0.09
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety ofacute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States. |
